Long-term effects of colestipol (U-26,597 A) on plasma lipids in familial type II hyperbetalipoproteinaemia

This publication has 11 references indexed in Scilit:

• The Effects of Colestipol Resin and of Colestipol Plus Clofibrate on the Turnover of Plasma Cholesterol in Man
  Journal of Clinical Investigation, 1973
• CONTROLLED CLINICAL TRIAL OF A NEW BILE ACID‐SEQUESTERING RESIN, COLESTIPOL, IN THE TREATMENT OF HYPERCHOLESTEROLEMIA
  The Medical Journal of Australia, 1973
• Colestipol and cholestyramine resin. Comparative effects in familial type II hyperlipoproteinemia
  JAMA, 1972
• The Effect of Colestipol or Cholestyramine on Serum Cholesterol and Triglycerides in a Long‐Term Controlled Study
  The Journal of Clinical Pharmacology and New Drugs, 1972
• Cholestyramine and nicotinic acid in the treatment of familial hyperbetalipoproteinaemia in the homozygous form
  Atherosclerosis, 1971
• Effects of colestipol (U-26,597A), a new bile acid sequestrant, on serum lipids in experimental animals and man
  Atherosclerosis, 1970
• The Current Status of Hypolipidemic Drugs
  Postgraduate Medicine, 1970
• LACK OF INHIBITION OF HEPATIC CHOLESTEROL SYNTHESIS BY DIETARY CHOLESTEROL IN CASES OF FAMILIAL HYPERCHOLESTEROLÆMIA
  The Lancet, 1969
• Eine neue Bestimmung der Neutralfette im Blutserum und Gewebe
  Klinische Wochenschrift, 1966
• A simple method for the determination of serum cholesterol
  Clinica Chimica Acta; International Journal of Clinical Chemistry, 1960